Business Wire

JenaValve Technology Closes $50 Million Financing

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic ...
Medscape

First TAVR for Aortic Regurgitation Moves to Phase 3 Trial

WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ...
FierceBiotech

Abbott completes first-in-human procedures for balloon-expanded TAVR heart implant

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first patient procedures with a yet-unnamed transcatheter aortic valve ...
Healio

‘Minimalist approach’ of local anesthesia without sedation safe for many during TAVR

Please provide your email address to receive an email when new articles are posted on . A strategy of local anesthesia without sedation was safe vs. conscious sedation for patients undergoing TAVR.
Medscape

FDA Approves TAVR in Asymptomatic Severe Stenosis

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA ...
Hosted on MSN

FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients

The US Food and Drug Administration (FDA) has approved Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for the treatment of patients with asymptomatic severe ...
FierceBiotech

At ESC 2025, new heart valve guidelines call for earlier TAVR as implant makers expand reach

At the annual meeting of the European Society of Cardiology (ESC), being held this weekend in Madrid, new cardiac care guidelines call for a more uniform, simplified and accessible approach to ...